Abingworth LLP - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 26 filers reported holding GW PHARMACEUTICALS PLC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
Abingworth LLP ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2014$6,067,000
+42.8%
102,2000.0%3.35%
+4.6%
Q4 2013$4,248,000
+144.6%
102,2000.0%3.20%
+223.3%
Q3 2013$1,737,000
+97.6%
102,2000.0%0.99%
+46.4%
Q2 2013$879,000102,2000.68%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2013
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 450,000$55,224,0004.41%
Parkman Healthcare Partners LLC 119,778$14,699,0004.14%
Sio Capital Management, LLC 94,984$11,656,0003.40%
Tamarack Advisers, LP 90,000$11,045,0003.08%
Copernicus Capital Management, LLC 22,000$2,700,0002.96%
Integral Health Asset Management, LLC 75,000$9,204,0002.76%
ETF MANAGERS GROUP, LLC 480,145$58,923,0002.09%
AdvisorShares Investments LLC 29,758$3,652,0001.55%
Redwood Investments, LLC 130,444$16,008,0001.42%
CLOUGH CAPITAL PARTNERS L P 100,746$12,364,0001.21%
View complete list of GW PHARMACEUTICALS PLC shareholders